Analytical Endpoint Testing
Champions Oncology’s Analytical Testing platforms can be used to gather additional data at the endpoint of a preclinical model or ex vivo assay.
Using multiplex cytokine assays with flow cytometry readouts, immune cell cytokine intracellular and extracellular staining upon activation can be assessed. Champions Oncology can also collect tissues from your in vivo studies and evaluate pathological changes throughout the tissue and/or the tumor itself using Immunohistochemistry (IHC) and other plate-based platforms (i.e. Luminex/ELISA platforms).